Vorinostat Completed Phase 1 Trials for Regional Neuroblastoma / Localized Unresectable Neuroblastoma / Recurrent Neuroblastoma / Stage 4 Neuroblastoma / Stage 4S Neuroblastoma Treatment

Indications	Status	Purpose	Phase
DBCOND0029100 (Regional Neuroblastoma) DBCOND0029572 (Localized Unresectable Neuroblastoma) DBCOND0028756 (Recurrent Neuroblastoma) DBCOND0029573 (Stage 4 Neuroblastoma) DBCOND0029574 (Stage 4S Neuroblastoma)	Completed	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT01208454	Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma	Tretinoin (DB00755) Isotretinoin (DB00982) Vorinostat (DB02546)